Earnings Call · Q1 FY2022·2022-05-09

Q1 22EPS -33.33%·Rev n/aQ4 21EPS 0.00%·Rev n/aQ3 21EPS +26.32%·Rev n/aQ2 21EPS -30.61%·Rev n/a⚠ consensus missing

aTYR PHARMA INC ATYR

Ashlee Dunston — Investor Relations or Communications

Sanjay Shukla — President and Chief Executive Officer

Jill Broadfoot — Chief Financial Officer

−3.1%1d on move date−3.3% vs SPY3d−15.9%5d−14.2%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ATYR calls or request research access.

More ATYR calls Browse calls Request research access